{"id":"https://openalex.org/W2998050720","doi":"https://doi.org/10.1056/nejmoa1908490","title":"Multiyear Follow-up of AAV5-hFVIII-SQ Gene Therapy for Hemophilia A","display_name":"Multiyear Follow-up of AAV5-hFVIII-SQ Gene Therapy for Hemophilia A","publication_year":2020,"publication_date":"2020-01-01","ids":{"openalex":"https://openalex.org/W2998050720","doi":"https://doi.org/10.1056/nejmoa1908490","mag":"2998050720","pmid":"https://pubmed.ncbi.nlm.nih.gov/31893514"},"language":"en","primary_location":{"id":"doi:10.1056/nejmoa1908490","doi":"https://doi.org/10.1056/nejmoa1908490","is_oa":true,"landing_page_url":"https://doi.org/10.1056/nejmoa1908490","pdf_url":"https://www.nejm.org/doi/pdf/10.1056/NEJMoa1908490?articleTools=true","source":{"id":"https://openalex.org/S62468778","display_name":"New England Journal of Medicine","issn_l":"0028-4793","issn":["0028-4793","0096-6762","1533-4406","2331-4710"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320239","host_organization_name":"Massachusetts Medical Society","host_organization_lineage":["https://openalex.org/P4310320239"],"host_organization_lineage_names":["Massachusetts Medical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"New England Journal of Medicine","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.nejm.org/doi/pdf/10.1056/NEJMoa1908490?articleTools=true","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5069063909","display_name":"John Pasi","orcid":"https://orcid.org/0000-0003-3394-2099","observed_orcids":["https://orcid.org/0000-0003-3394-2099"]},"institutions":[{"id":"https://openalex.org/I1308923049","display_name":"University Hospitals Birmingham NHS Foundation Trust","ror":"https://ror.org/014ja3n03","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1308923049"]},{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I200166805","display_name":"Guy's and St Thomas' NHS Foundation Trust","ror":"https://ror.org/00j161312","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I200166805"]},{"id":"https://openalex.org/I2802466933","display_name":"Cambridge University Hospitals NHS Foundation Trust","ror":"https://ror.org/04v54gj93","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802466933"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]},{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"K. John Pasi","raw_affiliation_strings":["From Barts and the London School of Medicine and Dentistry (K.J.P.), Guy\u2019s and St. Thomas\u2019 NHS Foundation Trust (B.M.), and the Centre for Haematology, Imperial College London (M. Laffan), London, University Hospital Southampton, Southampton (S.R.), University Hospitals Birmingham NHS Foundation Trust, Birmingham (W.L.), and Cambridge University Hospitals NHS Foundation Trust, Cambridge (E.S.) \u2014 all in the United Kingdom; and BioMarin Pharmaceutical, Novato (N.M., C.B.R., M. Li, W.Y.W.), and private","Barts and the London School of Medicine and Dentistry"],"raw_orcid":"https://orcid.org/0000-0003-3394-2099","affiliations":[{"raw_affiliation_string":"From Barts and the London School of Medicine and Dentistry (K.J.P.), Guy\u2019s and St. Thomas\u2019 NHS Foundation Trust (B.M.), and the Centre for Haematology, Imperial College London (M. Laffan), London, University Hospital Southampton, Southampton (S.R.), University Hospitals Birmingham NHS Foundation Trust, Birmingham (W.L.), and Cambridge University Hospitals NHS Foundation Trust, Cambridge (E.S.) \u2014 all in the United Kingdom; and BioMarin Pharmaceutical, Novato (N.M., C.B.R., M. Li, W.Y.W.), and private","institution_ids":["https://openalex.org/I1308923049","https://openalex.org/I166337079","https://openalex.org/I200166805","https://openalex.org/I2802466933","https://openalex.org/I45129253","https://openalex.org/I47508984"]},{"raw_affiliation_string":"Barts and the London School of Medicine and Dentistry","institution_ids":["https://openalex.org/I166337079"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021470371","display_name":"Savita Rangarajan","orcid":"https://orcid.org/0000-0001-7367-133X","observed_orcids":["https://orcid.org/0000-0001-7367-133X"]},"institutions":[{"id":"https://openalex.org/I1308923049","display_name":"University Hospitals Birmingham NHS Foundation Trust","ror":"https://ror.org/014ja3n03","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1308923049"]},{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I200166805","display_name":"Guy's and St Thomas' NHS Foundation Trust","ror":"https://ror.org/00j161312","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I200166805"]},{"id":"https://openalex.org/I2802466933","display_name":"Cambridge University Hospitals NHS Foundation Trust","ror":"https://ror.org/04v54gj93","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802466933"]},{"id":"https://openalex.org/I2802965805","display_name":"University Hospital Southampton NHS Foundation Trust","ror":"https://ror.org/0485axj58","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802965805"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]},{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Savita Rangarajan","raw_affiliation_strings":["From Barts and the London School of Medicine and Dentistry (K.J.P.), Guy\u2019s and St. Thomas\u2019 NHS Foundation Trust (B.M.), and the Centre for Haematology, Imperial College London (M. Laffan), London, University Hospital Southampton, Southampton (S.R.), University Hospitals Birmingham NHS Foundation Trust, Birmingham (W.L.), and Cambridge University Hospitals NHS Foundation Trust, Cambridge (E.S.) \u2014 all in the United Kingdom; and BioMarin Pharmaceutical, Novato (N.M., C.B.R., M. Li, W.Y.W.), and private","London, University Hospital Southampton, Southampton"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Barts and the London School of Medicine and Dentistry (K.J.P.), Guy\u2019s and St. Thomas\u2019 NHS Foundation Trust (B.M.), and the Centre for Haematology, Imperial College London (M. Laffan), London, University Hospital Southampton, Southampton (S.R.), University Hospitals Birmingham NHS Foundation Trust, Birmingham (W.L.), and Cambridge University Hospitals NHS Foundation Trust, Cambridge (E.S.) \u2014 all in the United Kingdom; and BioMarin Pharmaceutical, Novato (N.M., C.B.R., M. Li, W.Y.W.), and private","institution_ids":["https://openalex.org/I1308923049","https://openalex.org/I166337079","https://openalex.org/I200166805","https://openalex.org/I2802466933","https://openalex.org/I45129253","https://openalex.org/I47508984"]},{"raw_affiliation_string":"London, University Hospital Southampton, Southampton","institution_ids":["https://openalex.org/I2802965805"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110170086","display_name":"Nina Mitchell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1308923049","display_name":"University Hospitals Birmingham NHS Foundation Trust","ror":"https://ror.org/014ja3n03","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1308923049"]},{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I200166805","display_name":"Guy's and St Thomas' NHS Foundation Trust","ror":"https://ror.org/00j161312","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I200166805"]},{"id":"https://openalex.org/I2802466933","display_name":"Cambridge University Hospitals NHS Foundation Trust","ror":"https://ror.org/04v54gj93","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802466933"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]},{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Nina Mitchell","raw_affiliation_strings":["From Barts and the London School of Medicine and Dentistry (K.J.P.), Guy\u2019s and St. Thomas\u2019 NHS Foundation Trust (B.M.), and the Centre for Haematology, Imperial College London (M. Laffan), London, University Hospital Southampton, Southampton (S.R.), University Hospitals Birmingham NHS Foundation Trust, Birmingham (W.L.), and Cambridge University Hospitals NHS Foundation Trust, Cambridge (E.S.) \u2014 all in the United Kingdom; and BioMarin Pharmaceutical, Novato (N.M., C.B.R., M. Li, W.Y.W.), and private","BioMarin Pharmaceutical, Novato"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Barts and the London School of Medicine and Dentistry (K.J.P.), Guy\u2019s and St. Thomas\u2019 NHS Foundation Trust (B.M.), and the Centre for Haematology, Imperial College London (M. Laffan), London, University Hospital Southampton, Southampton (S.R.), University Hospitals Birmingham NHS Foundation Trust, Birmingham (W.L.), and Cambridge University Hospitals NHS Foundation Trust, Cambridge (E.S.) \u2014 all in the United Kingdom; and BioMarin Pharmaceutical, Novato (N.M., C.B.R., M. Li, W.Y.W.), and private","institution_ids":["https://openalex.org/I1308923049","https://openalex.org/I166337079","https://openalex.org/I200166805","https://openalex.org/I2802466933","https://openalex.org/I45129253","https://openalex.org/I47508984"]},{"raw_affiliation_string":"BioMarin Pharmaceutical, Novato","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020057448","display_name":"Will Lester","orcid":"https://orcid.org/0000-0001-8790-7112","observed_orcids":["https://orcid.org/0000-0001-8790-7112"]},"institutions":[{"id":"https://openalex.org/I1308923049","display_name":"University Hospitals Birmingham NHS Foundation Trust","ror":"https://ror.org/014ja3n03","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1308923049"]},{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I200166805","display_name":"Guy's and St Thomas' NHS Foundation Trust","ror":"https://ror.org/00j161312","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I200166805"]},{"id":"https://openalex.org/I2802466933","display_name":"Cambridge University Hospitals NHS Foundation Trust","ror":"https://ror.org/04v54gj93","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802466933"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]},{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Will Lester","raw_affiliation_strings":["From Barts and the London School of Medicine and Dentistry (K.J.P.), Guy\u2019s and St. Thomas\u2019 NHS Foundation Trust (B.M.), and the Centre for Haematology, Imperial College London (M. Laffan), London, University Hospital Southampton, Southampton (S.R.), University Hospitals Birmingham NHS Foundation Trust, Birmingham (W.L.), and Cambridge University Hospitals NHS Foundation Trust, Cambridge (E.S.) \u2014 all in the United Kingdom; and BioMarin Pharmaceutical, Novato (N.M., C.B.R., M. Li, W.Y.W.), and private","University Hospitals Birmingham NHS Foundation Trust, Birmingham"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Barts and the London School of Medicine and Dentistry (K.J.P.), Guy\u2019s and St. Thomas\u2019 NHS Foundation Trust (B.M.), and the Centre for Haematology, Imperial College London (M. Laffan), London, University Hospital Southampton, Southampton (S.R.), University Hospitals Birmingham NHS Foundation Trust, Birmingham (W.L.), and Cambridge University Hospitals NHS Foundation Trust, Cambridge (E.S.) \u2014 all in the United Kingdom; and BioMarin Pharmaceutical, Novato (N.M., C.B.R., M. Li, W.Y.W.), and private","institution_ids":["https://openalex.org/I1308923049","https://openalex.org/I166337079","https://openalex.org/I200166805","https://openalex.org/I2802466933","https://openalex.org/I45129253","https://openalex.org/I47508984"]},{"raw_affiliation_string":"University Hospitals Birmingham NHS Foundation Trust, Birmingham","institution_ids":["https://openalex.org/I1308923049"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058546945","display_name":"Emily M. Symington","orcid":"https://orcid.org/0000-0003-2529-8168","observed_orcids":["https://orcid.org/0000-0003-2529-8168"]},"institutions":[{"id":"https://openalex.org/I1308923049","display_name":"University Hospitals Birmingham NHS Foundation Trust","ror":"https://ror.org/014ja3n03","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1308923049"]},{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I200166805","display_name":"Guy's and St Thomas' NHS Foundation Trust","ror":"https://ror.org/00j161312","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I200166805"]},{"id":"https://openalex.org/I2802466933","display_name":"Cambridge University Hospitals NHS Foundation Trust","ror":"https://ror.org/04v54gj93","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802466933"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]},{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Emily Symington","raw_affiliation_strings":["From Barts and the London School of Medicine and Dentistry (K.J.P.), Guy\u2019s and St. Thomas\u2019 NHS Foundation Trust (B.M.), and the Centre for Haematology, Imperial College London (M. Laffan), London, University Hospital Southampton, Southampton (S.R.), University Hospitals Birmingham NHS Foundation Trust, Birmingham (W.L.), and Cambridge University Hospitals NHS Foundation Trust, Cambridge (E.S.) \u2014 all in the United Kingdom; and BioMarin Pharmaceutical, Novato (N.M., C.B.R., M. Li, W.Y.W.), and private","Cambridge University Hospitals NHS Foundation Trust, Cambridge"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Barts and the London School of Medicine and Dentistry (K.J.P.), Guy\u2019s and St. Thomas\u2019 NHS Foundation Trust (B.M.), and the Centre for Haematology, Imperial College London (M. Laffan), London, University Hospital Southampton, Southampton (S.R.), University Hospitals Birmingham NHS Foundation Trust, Birmingham (W.L.), and Cambridge University Hospitals NHS Foundation Trust, Cambridge (E.S.) \u2014 all in the United Kingdom; and BioMarin Pharmaceutical, Novato (N.M., C.B.R., M. Li, W.Y.W.), and private","institution_ids":["https://openalex.org/I1308923049","https://openalex.org/I166337079","https://openalex.org/I200166805","https://openalex.org/I2802466933","https://openalex.org/I45129253","https://openalex.org/I47508984"]},{"raw_affiliation_string":"Cambridge University Hospitals NHS Foundation Trust, Cambridge","institution_ids":["https://openalex.org/I2802466933"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112337941","display_name":"Bella Madan","orcid":"https://orcid.org/0000-0003-4858-4888","observed_orcids":["https://orcid.org/0000-0003-4858-4888"]},"institutions":[{"id":"https://openalex.org/I1308923049","display_name":"University Hospitals Birmingham NHS Foundation Trust","ror":"https://ror.org/014ja3n03","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1308923049"]},{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I200166805","display_name":"Guy's and St Thomas' NHS Foundation Trust","ror":"https://ror.org/00j161312","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I200166805"]},{"id":"https://openalex.org/I2802466933","display_name":"Cambridge University Hospitals NHS Foundation Trust","ror":"https://ror.org/04v54gj93","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802466933"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]},{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Bella Madan","raw_affiliation_strings":["From Barts and the London School of Medicine and Dentistry (K.J.P.), Guy\u2019s and St. Thomas\u2019 NHS Foundation Trust (B.M.), and the Centre for Haematology, Imperial College London (M. Laffan), London, University Hospital Southampton, Southampton (S.R.), University Hospitals Birmingham NHS Foundation Trust, Birmingham (W.L.), and Cambridge University Hospitals NHS Foundation Trust, Cambridge (E.S.) \u2014 all in the United Kingdom; and BioMarin Pharmaceutical, Novato (N.M., C.B.R., M. Li, W.Y.W.), and private","Guy's and St. Thomas' NHS Foundation Trust"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Barts and the London School of Medicine and Dentistry (K.J.P.), Guy\u2019s and St. Thomas\u2019 NHS Foundation Trust (B.M.), and the Centre for Haematology, Imperial College London (M. Laffan), London, University Hospital Southampton, Southampton (S.R.), University Hospitals Birmingham NHS Foundation Trust, Birmingham (W.L.), and Cambridge University Hospitals NHS Foundation Trust, Cambridge (E.S.) \u2014 all in the United Kingdom; and BioMarin Pharmaceutical, Novato (N.M., C.B.R., M. Li, W.Y.W.), and private","institution_ids":["https://openalex.org/I1308923049","https://openalex.org/I166337079","https://openalex.org/I200166805","https://openalex.org/I2802466933","https://openalex.org/I45129253","https://openalex.org/I47508984"]},{"raw_affiliation_string":"Guy's and St. Thomas' NHS Foundation Trust","institution_ids":["https://openalex.org/I200166805"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039321983","display_name":"Michael Laffan","orcid":"https://orcid.org/0000-0002-8268-3268","observed_orcids":["https://orcid.org/0000-0002-8268-3268"]},"institutions":[{"id":"https://openalex.org/I1308923049","display_name":"University Hospitals Birmingham NHS Foundation Trust","ror":"https://ror.org/014ja3n03","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1308923049"]},{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I200166805","display_name":"Guy's and St Thomas' NHS Foundation Trust","ror":"https://ror.org/00j161312","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I200166805"]},{"id":"https://openalex.org/I2802466933","display_name":"Cambridge University Hospitals NHS Foundation Trust","ror":"https://ror.org/04v54gj93","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802466933"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]},{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Michael Laffan","raw_affiliation_strings":["From Barts and the London School of Medicine and Dentistry (K.J.P.), Guy\u2019s and St. Thomas\u2019 NHS Foundation Trust (B.M.), and the Centre for Haematology, Imperial College London (M. Laffan), London, University Hospital Southampton, Southampton (S.R.), University Hospitals Birmingham NHS Foundation Trust, Birmingham (W.L.), and Cambridge University Hospitals NHS Foundation Trust, Cambridge (E.S.) \u2014 all in the United Kingdom; and BioMarin Pharmaceutical, Novato (N.M., C.B.R., M. Li, W.Y.W.), and private","Centre for Haematology, Imperial College London"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Barts and the London School of Medicine and Dentistry (K.J.P.), Guy\u2019s and St. Thomas\u2019 NHS Foundation Trust (B.M.), and the Centre for Haematology, Imperial College London (M. Laffan), London, University Hospital Southampton, Southampton (S.R.), University Hospitals Birmingham NHS Foundation Trust, Birmingham (W.L.), and Cambridge University Hospitals NHS Foundation Trust, Cambridge (E.S.) \u2014 all in the United Kingdom; and BioMarin Pharmaceutical, Novato (N.M., C.B.R., M. Li, W.Y.W.), and private","institution_ids":["https://openalex.org/I1308923049","https://openalex.org/I166337079","https://openalex.org/I200166805","https://openalex.org/I2802466933","https://openalex.org/I45129253","https://openalex.org/I47508984"]},{"raw_affiliation_string":"Centre for Haematology, Imperial College London","institution_ids":["https://openalex.org/I47508984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070208317","display_name":"Chris B. Russell","orcid":"https://orcid.org/0000-0002-0240-1815","observed_orcids":["https://orcid.org/0000-0002-0240-1815"]},"institutions":[{"id":"https://openalex.org/I1308923049","display_name":"University Hospitals Birmingham NHS Foundation Trust","ror":"https://ror.org/014ja3n03","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1308923049"]},{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I200166805","display_name":"Guy's and St Thomas' NHS Foundation Trust","ror":"https://ror.org/00j161312","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I200166805"]},{"id":"https://openalex.org/I2802466933","display_name":"Cambridge University Hospitals NHS Foundation Trust","ror":"https://ror.org/04v54gj93","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802466933"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]},{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Chris B. Russell","raw_affiliation_strings":["From Barts and the London School of Medicine and Dentistry (K.J.P.), Guy\u2019s and St. Thomas\u2019 NHS Foundation Trust (B.M.), and the Centre for Haematology, Imperial College London (M. Laffan), London, University Hospital Southampton, Southampton (S.R.), University Hospitals Birmingham NHS Foundation Trust, Birmingham (W.L.), and Cambridge University Hospitals NHS Foundation Trust, Cambridge (E.S.) \u2014 all in the United Kingdom; and BioMarin Pharmaceutical, Novato (N.M., C.B.R., M. Li, W.Y.W.), and private","BioMarin Pharmaceutical, Novato"],"raw_orcid":"https://orcid.org/0000-0002-0240-1815","affiliations":[{"raw_affiliation_string":"From Barts and the London School of Medicine and Dentistry (K.J.P.), Guy\u2019s and St. Thomas\u2019 NHS Foundation Trust (B.M.), and the Centre for Haematology, Imperial College London (M. Laffan), London, University Hospital Southampton, Southampton (S.R.), University Hospitals Birmingham NHS Foundation Trust, Birmingham (W.L.), and Cambridge University Hospitals NHS Foundation Trust, Cambridge (E.S.) \u2014 all in the United Kingdom; and BioMarin Pharmaceutical, Novato (N.M., C.B.R., M. Li, W.Y.W.), and private","institution_ids":["https://openalex.org/I1308923049","https://openalex.org/I166337079","https://openalex.org/I200166805","https://openalex.org/I2802466933","https://openalex.org/I45129253","https://openalex.org/I47508984"]},{"raw_affiliation_string":"BioMarin Pharmaceutical, Novato","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063869163","display_name":"Mingjin Li","orcid":"https://orcid.org/0000-0002-1768-2613","observed_orcids":["https://orcid.org/0000-0002-1768-2613"]},"institutions":[{"id":"https://openalex.org/I1308923049","display_name":"University Hospitals Birmingham NHS Foundation Trust","ror":"https://ror.org/014ja3n03","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1308923049"]},{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I200166805","display_name":"Guy's and St Thomas' NHS Foundation Trust","ror":"https://ror.org/00j161312","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I200166805"]},{"id":"https://openalex.org/I2802466933","display_name":"Cambridge University Hospitals NHS Foundation Trust","ror":"https://ror.org/04v54gj93","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802466933"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]},{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Mingjin Li","raw_affiliation_strings":["From Barts and the London School of Medicine and Dentistry (K.J.P.), Guy\u2019s and St. Thomas\u2019 NHS Foundation Trust (B.M.), and the Centre for Haematology, Imperial College London (M. Laffan), London, University Hospital Southampton, Southampton (S.R.), University Hospitals Birmingham NHS Foundation Trust, Birmingham (W.L.), and Cambridge University Hospitals NHS Foundation Trust, Cambridge (E.S.) \u2014 all in the United Kingdom; and BioMarin Pharmaceutical, Novato (N.M., C.B.R., M. Li, W.Y.W.), and private","BioMarin Pharmaceutical, Novato"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Barts and the London School of Medicine and Dentistry (K.J.P.), Guy\u2019s and St. Thomas\u2019 NHS Foundation Trust (B.M.), and the Centre for Haematology, Imperial College London (M. Laffan), London, University Hospital Southampton, Southampton (S.R.), University Hospitals Birmingham NHS Foundation Trust, Birmingham (W.L.), and Cambridge University Hospitals NHS Foundation Trust, Cambridge (E.S.) \u2014 all in the United Kingdom; and BioMarin Pharmaceutical, Novato (N.M., C.B.R., M. Li, W.Y.W.), and private","institution_ids":["https://openalex.org/I1308923049","https://openalex.org/I166337079","https://openalex.org/I200166805","https://openalex.org/I2802466933","https://openalex.org/I45129253","https://openalex.org/I47508984"]},{"raw_affiliation_string":"BioMarin Pharmaceutical, Novato","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076779935","display_name":"Glenn F. Pierce","orcid":"https://orcid.org/0000-0002-3310-328X","observed_orcids":["https://orcid.org/0000-0002-3310-328X"]},"institutions":[{"id":"https://openalex.org/I1308923049","display_name":"University Hospitals Birmingham NHS Foundation Trust","ror":"https://ror.org/014ja3n03","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1308923049"]},{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I200166805","display_name":"Guy's and St Thomas' NHS Foundation Trust","ror":"https://ror.org/00j161312","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I200166805"]},{"id":"https://openalex.org/I2802466933","display_name":"Cambridge University Hospitals NHS Foundation Trust","ror":"https://ror.org/04v54gj93","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802466933"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]},{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Glenn F. Pierce","raw_affiliation_strings":["From Barts and the London School of Medicine and Dentistry (K.J.P.), Guy\u2019s and St. Thomas\u2019 NHS Foundation Trust (B.M.), and the Centre for Haematology, Imperial College London (M. Laffan), London, University Hospital Southampton, Southampton (S.R.), University Hospitals Birmingham NHS Foundation Trust, Birmingham (W.L.), and Cambridge University Hospitals NHS Foundation Trust, Cambridge (E.S.) \u2014 all in the United Kingdom; and BioMarin Pharmaceutical, Novato (N.M., C.B.R., M. Li, W.Y.W.), and private","private consultant, La Jolla"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Barts and the London School of Medicine and Dentistry (K.J.P.), Guy\u2019s and St. Thomas\u2019 NHS Foundation Trust (B.M.), and the Centre for Haematology, Imperial College London (M. Laffan), London, University Hospital Southampton, Southampton (S.R.), University Hospitals Birmingham NHS Foundation Trust, Birmingham (W.L.), and Cambridge University Hospitals NHS Foundation Trust, Cambridge (E.S.) \u2014 all in the United Kingdom; and BioMarin Pharmaceutical, Novato (N.M., C.B.R., M. Li, W.Y.W.), and private","institution_ids":["https://openalex.org/I1308923049","https://openalex.org/I166337079","https://openalex.org/I200166805","https://openalex.org/I2802466933","https://openalex.org/I45129253","https://openalex.org/I47508984"]},{"raw_affiliation_string":"private consultant, La Jolla","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112432771","display_name":"Wing Yen Wong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1308923049","display_name":"University Hospitals Birmingham NHS Foundation Trust","ror":"https://ror.org/014ja3n03","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1308923049"]},{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I200166805","display_name":"Guy's and St Thomas' NHS Foundation Trust","ror":"https://ror.org/00j161312","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I200166805"]},{"id":"https://openalex.org/I2802466933","display_name":"Cambridge University Hospitals NHS Foundation Trust","ror":"https://ror.org/04v54gj93","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802466933"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]},{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Wing Y. Wong","raw_affiliation_strings":["From Barts and the London School of Medicine and Dentistry (K.J.P.), Guy\u2019s and St. Thomas\u2019 NHS Foundation Trust (B.M.), and the Centre for Haematology, Imperial College London (M. Laffan), London, University Hospital Southampton, Southampton (S.R.), University Hospitals Birmingham NHS Foundation Trust, Birmingham (W.L.), and Cambridge University Hospitals NHS Foundation Trust, Cambridge (E.S.) \u2014 all in the United Kingdom; and BioMarin Pharmaceutical, Novato (N.M., C.B.R., M. Li, W.Y.W.), and private","BioMarin Pharmaceutical, Novato"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Barts and the London School of Medicine and Dentistry (K.J.P.), Guy\u2019s and St. Thomas\u2019 NHS Foundation Trust (B.M.), and the Centre for Haematology, Imperial College London (M. Laffan), London, University Hospital Southampton, Southampton (S.R.), University Hospitals Birmingham NHS Foundation Trust, Birmingham (W.L.), and Cambridge University Hospitals NHS Foundation Trust, Cambridge (E.S.) \u2014 all in the United Kingdom; and BioMarin Pharmaceutical, Novato (N.M., C.B.R., M. Li, W.Y.W.), and private","institution_ids":["https://openalex.org/I1308923049","https://openalex.org/I166337079","https://openalex.org/I200166805","https://openalex.org/I2802466933","https://openalex.org/I45129253","https://openalex.org/I47508984"]},{"raw_affiliation_string":"BioMarin Pharmaceutical, Novato","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":7,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":48.6085,"has_fulltext":true,"cited_by_count":449,"citation_normalized_percentile":{"value":0.99900055,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"382","issue":"1","first_page":"29","last_page":"40"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11280","display_name":"Hemophilia Treatment and Research","score":0.9810000061988831,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11280","display_name":"Hemophilia Treatment and Research","score":0.9810000061988831,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.018799999728798866,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hemophilia-a","display_name":"hemophilia A","score":0.9620000123977661},{"id":"https://openalex.org/keywords/adeno-associated-virus-gene-therapy","display_name":"adeno-associated virus gene therapy","score":0.9449999928474426},{"id":"https://openalex.org/keywords/factor-viii","display_name":"factor VIII","score":0.7440000176429749},{"id":"https://openalex.org/keywords/long-term-safety","display_name":"long-term safety","score":0.7710000276565552},{"id":"https://openalex.org/keywords/annualized-bleeding-rate","display_name":"annualized bleeding rate","score":0.8889999985694885},{"id":"https://openalex.org/keywords/transgene-expression-kinetics","display_name":"transgene expression kinetics","score":0.6729999780654907}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8853961229324341},{"id":"https://openalex.org/C2781221834","wikidata":"https://www.wikidata.org/wiki/Q425360","display_name":"Factor IX","level":2,"score":0.5406659841537476},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.418049693107605},{"id":"https://openalex.org/C147583825","wikidata":"https://www.wikidata.org/wiki/Q620876","display_name":"Body weight","level":2,"score":0.4142317771911621},{"id":"https://openalex.org/C111599444","wikidata":"https://www.wikidata.org/wiki/Q213901","display_name":"Genetic enhancement","level":3,"score":0.4130953550338745},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.40870583057403564},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3817279040813446},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.09792613983154297},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000229","descriptor_name":"Dependovirus","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003029","descriptor_name":"Coagulants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005169","descriptor_name":"Factor VIII","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D005169","descriptor_name":"Factor VIII","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005822","descriptor_name":"Genetic Vectors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006467","descriptor_name":"Hemophilia A","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D006467","descriptor_name":"Hemophilia A","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D006470","descriptor_name":"Hemorrhage","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D006470","descriptor_name":"Hemorrhage","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007262","descriptor_name":"Infusions, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015316","descriptor_name":"Genetic Therapy","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019076","descriptor_name":"Transgenes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1056/nejmoa1908490","doi":"https://doi.org/10.1056/nejmoa1908490","is_oa":true,"landing_page_url":"https://doi.org/10.1056/nejmoa1908490","pdf_url":"https://www.nejm.org/doi/pdf/10.1056/NEJMoa1908490?articleTools=true","source":{"id":"https://openalex.org/S62468778","display_name":"New England Journal of Medicine","issn_l":"0028-4793","issn":["0028-4793","0096-6762","1533-4406","2331-4710"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320239","host_organization_name":"Massachusetts Medical Society","host_organization_lineage":["https://openalex.org/P4310320239"],"host_organization_lineage_names":["Massachusetts Medical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"New England Journal of Medicine","raw_type":"journal-article"},{"id":"pmid:31893514","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31893514","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The New England journal of medicine","raw_type":"Clinical Trial, Phase I"},{"id":"pmh:oai:eprints.soton.ac.uk:442594","doi":null,"is_oa":false,"landing_page_url":"https://eprints.soton.ac.uk/442594/","pdf_url":null,"source":{"id":"https://openalex.org/S4306401019","display_name":"ePrints Soton (University of Southampton)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I43439940","host_organization_name":"University of Southampton","host_organization_lineage":["https://openalex.org/I43439940"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Article"},{"id":"pmh:oai:qmro.qmul.ac.uk:123456789/64326","doi":null,"is_oa":false,"landing_page_url":"https://qmro.qmul.ac.uk/xmlui/handle/123456789/64326","pdf_url":null,"source":{"id":"https://openalex.org/S4306400530","display_name":"Queen Mary Research Online (Queen Mary University of London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I166337079","host_organization_name":"Queen Mary University of London","host_organization_lineage":["https://openalex.org/I166337079"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Article"},{"id":"pmh:oai:spiral.imperial.ac.uk:10044/1/75763","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/10044/1/75763","pdf_url":null,"source":{"id":"https://openalex.org/S4306401396","display_name":"Spiral (Imperial College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I47508984","host_organization_name":"Imperial College London","host_organization_lineage":["https://openalex.org/I47508984"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"40","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1056/nejmoa1908490","doi":"https://doi.org/10.1056/nejmoa1908490","is_oa":true,"landing_page_url":"https://doi.org/10.1056/nejmoa1908490","pdf_url":"https://www.nejm.org/doi/pdf/10.1056/NEJMoa1908490?articleTools=true","source":{"id":"https://openalex.org/S62468778","display_name":"New England Journal of Medicine","issn_l":"0028-4793","issn":["0028-4793","0096-6762","1533-4406","2331-4710"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320239","host_organization_name":"Massachusetts Medical Society","host_organization_lineage":["https://openalex.org/P4310320239"],"host_organization_lineage_names":["Massachusetts Medical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"New England Journal of Medicine","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320310557","display_name":"BioMarin Pharmaceutical","ror":"https://ror.org/03fmvqd28"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2998050720.pdf","grobid_xml":"https://content.openalex.org/works/W2998050720.grobid-xml"},"referenced_works_count":29,"referenced_works":["https://openalex.org/W1648736195","https://openalex.org/W1678213225","https://openalex.org/W1934803189","https://openalex.org/W1969271703","https://openalex.org/W1976329054","https://openalex.org/W1979659851","https://openalex.org/W1991453997","https://openalex.org/W1999760686","https://openalex.org/W2008289270","https://openalex.org/W2020123164","https://openalex.org/W2055198158","https://openalex.org/W2067074806","https://openalex.org/W2079947715","https://openalex.org/W2098079634","https://openalex.org/W2113438234","https://openalex.org/W2113444875","https://openalex.org/W2119164964","https://openalex.org/W2139210573","https://openalex.org/W2147366976","https://openalex.org/W2150202137","https://openalex.org/W2193386956","https://openalex.org/W2560734435","https://openalex.org/W2601037689","https://openalex.org/W2765253110","https://openalex.org/W2767505578","https://openalex.org/W2774984285","https://openalex.org/W2775538622","https://openalex.org/W2806553064","https://openalex.org/W2935758806"],"related_works":["https://openalex.org/W4411198299","https://openalex.org/W4403173798","https://openalex.org/W2775538622","https://openalex.org/W2058518705","https://openalex.org/W4310095961","https://openalex.org/W3211832397","https://openalex.org/W4229038960","https://openalex.org/W4389248161","https://openalex.org/W4246057453","https://openalex.org/W7098829252"],"abstract_inverted_index":{"BACKGROUND:":[0],"Adeno-associated":[1],"virus":[2],"(AAV)-mediated":[3],"gene":[4,216],"therapy":[5],"is":[6],"under":[7],"investigation":[8],"as":[9],"a":[10,28,62,105],"therapeutic":[11],"option":[12],"for":[13,95,170],"persons":[14],"with":[15,48,177],"hemophilia":[16,50],"A.":[17],"Efficacy":[18],"and":[19,40,42,89,124,162],"safety":[20],"data":[21],"include":[22],"3":[23,98],"years":[24],"of":[25,31,65,79,83,92,110,119,128,148,214],"follow-up":[26],"after":[27],"single":[29,63],"administration":[30],"AAV5-hFVIII-SQ.":[32],"METHODS:":[33],"We":[34,71],"report":[35],"durable":[36],"efficacy,":[37],"long-term":[38],"safety,":[39,86],"clinical":[41],"biologic":[43,90],"results":[44],"in":[45,142,146,159,180,194,205],"15":[46],"adults":[47],"severe":[49],"A":[51],"(factor":[52],"VIII":[53,75,108,130,153,187],"level,":[54,76],"\u22641":[55],"IU":[56,112],"per":[57,102,113,139,212],"deciliter)":[58],"who":[59],"had":[60,104],"received":[61],"infusion":[64],"AAV5-hFVIII-SQ":[66],"at":[67],"various":[68],"dose":[69],"levels.":[70],"evaluated":[72],"the":[73,115,125,160,215],"factor":[74,84,107,129,152,186],"annualized":[77,117],"rate":[78,118],"bleeding":[80,120],"events,":[81],"use":[82,127],"VIII,":[85],"expression":[87,109],"kinetics,":[88],"markers":[91],"AAV":[93],"transduction":[94],"up":[96],"to":[97,136,166],"years.":[99],"RESULTS:":[100],"vg":[101,211],"kilogram)":[103],"median":[106,116,126],"13":[111],"deciliter;":[114],"events":[121,164],"was":[122,131],"0,":[123],"reduced":[132],"from":[133],"155.5":[134],"infusions":[135,138],"0.5":[137],"year.":[140],"Bleeding":[141],"target":[143],"joints":[144],"resolved":[145],"five":[147],"six":[149],"participants.":[150],"The":[151],"pharmacodynamic":[154],"profiles":[155],"reflected":[156],"cellular":[157],"turnover":[158],"blood":[161],"molecular":[163],"leading":[165],"episomal":[167],"DNA":[168],"stabilization":[169],"persistent":[171,203],"expression,":[172],"findings":[173],"that":[174],"are":[175],"consistent":[176],"previous":[178],"observations":[179],"two":[181],"model":[182],"systems.":[183],"Transgene-derived":[184],"human":[185],"(hFVIII)":[188],"protein":[189],"activity":[190],"mirrored":[191],"native":[192],"hFVIII":[193],"hemostatic":[195],"ability.":[196],"No":[197],"inhibitor":[198],"development,":[199],"thromboses,":[200],"deaths,":[201],"or":[202],"changes":[204],"liver-function":[206],"tests":[207],"were":[208],"observed.":[209],"CONCLUSIONS:":[210],"kilogram":[213],"therapy.":[217],"(Funded":[218],"by":[219],"BioMarin":[220],"Pharmaceutical;":[221],"ClinicalTrials.gov":[222],"number,":[223,226],"NCT02576795;":[224],"EudraCT":[225],"2014-003880-38.).":[227]},"counts_by_year":[{"year":2026,"cited_by_count":30},{"year":2025,"cited_by_count":52},{"year":2024,"cited_by_count":59},{"year":2023,"cited_by_count":67},{"year":2022,"cited_by_count":96},{"year":2021,"cited_by_count":72},{"year":2020,"cited_by_count":73}],"updated_date":"2026-11-03T10:50:19.383937","created_date":"2020-01-10T00:00:00"}